Review



deep learning designer tool  (MathWorks Inc)


Bioz Verified Symbol MathWorks Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    MathWorks Inc deep learning designer tool
    Deep Learning Designer Tool, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/deep learning designer tool/product/MathWorks Inc
    Average 90 stars, based on 1 article reviews
    deep learning designer tool - by Bioz Stars, 2026-04
    90/100 stars

    Images



    Similar Products

    90
    MathWorks Inc deep learning designer tool
    Deep Learning Designer Tool, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/deep learning designer tool/product/MathWorks Inc
    Average 90 stars, based on 1 article reviews
    deep learning designer tool - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Atomwise Inc deep learning platform for structure-based drug design
    List of companies using AI and ML technologies in pharmaceutical research as discussed by [ <xref ref-type= 102 , 103 , 104 ]." width="250" height="auto" />
    Deep Learning Platform For Structure Based Drug Design, supplied by Atomwise Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/deep learning platform for structure-based drug design/product/Atomwise Inc
    Average 90 stars, based on 1 article reviews
    deep learning platform for structure-based drug design - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Photonics Inc deep learning and adjoint method accelerated inverse design in
    List of companies using AI and ML technologies in pharmaceutical research as discussed by [ <xref ref-type= 102 , 103 , 104 ]." width="250" height="auto" />
    Deep Learning And Adjoint Method Accelerated Inverse Design In, supplied by Photonics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/deep learning and adjoint method accelerated inverse design in/product/Photonics Inc
    Average 90 stars, based on 1 article reviews
    deep learning and adjoint method accelerated inverse design in - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Infocom Corp deep-learning-based link adaptation design
    List of companies using AI and ML technologies in pharmaceutical research as discussed by [ <xref ref-type= 102 , 103 , 104 ]." width="250" height="auto" />
    Deep Learning Based Link Adaptation Design, supplied by Infocom Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/deep-learning-based link adaptation design/product/Infocom Corp
    Average 90 stars, based on 1 article reviews
    deep-learning-based link adaptation design - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    MathWorks Inc deep learning designer function
    List of companies using AI and ML technologies in pharmaceutical research as discussed by [ <xref ref-type= 102 , 103 , 104 ]." width="250" height="auto" />
    Deep Learning Designer Function, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/deep learning designer function/product/MathWorks Inc
    Average 90 stars, based on 1 article reviews
    deep learning designer function - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    MathWorks Inc deep learning designer
    List of companies using AI and ML technologies in pharmaceutical research as discussed by [ <xref ref-type= 102 , 103 , 104 ]." width="250" height="auto" />
    Deep Learning Designer, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/deep learning designer/product/MathWorks Inc
    Average 90 stars, based on 1 article reviews
    deep learning designer - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    96
    MathWorks Inc deep network designer tool
    List of companies using AI and ML technologies in pharmaceutical research as discussed by [ <xref ref-type= 102 , 103 , 104 ]." width="250" height="auto" />
    Deep Network Designer Tool, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/deep network designer tool/product/MathWorks Inc
    Average 96 stars, based on 1 article reviews
    deep network designer tool - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    90
    Mirai INC deep-learning model designed for breast cancer risk assessment
    List of companies using AI and ML technologies in pharmaceutical research as discussed by [ <xref ref-type= 102 , 103 , 104 ]." width="250" height="auto" />
    Deep Learning Model Designed For Breast Cancer Risk Assessment, supplied by Mirai INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/deep-learning model designed for breast cancer risk assessment/product/Mirai INC
    Average 90 stars, based on 1 article reviews
    deep-learning model designed for breast cancer risk assessment - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    AstraZeneca ltd deep reinforcement learning based molecular de novo design method
    ( A ) The identification of ten commercial-accessible aromatic fragments aided by deep <t>reinforcement</t> learning model; ( B ) Synthesis of LFS-1107 via the installation of aromatic tetrazole moiety selected from the previous step to the sulforaphene parent structure; ( C ) Assessment of protein-ligand binding kinetics and binding affinity of tetrazole aromatic fragments via Bio-layer interferometry (BLI) assay; ( D ) Binding affinity of LFS-1107 and KPT-330 determined via BLI assay: LFS-1107, K d ~1.25E-11 M; KPT-330: K d ~5.29E-09 M. Figure 1—source data 1. The chemical structure of 10 commercial-accessible aromatic fragments. Figure 1—source data 2. The synthesis of compound LFS-1107. Figure 1—source data 3. The data of affinities and binding kinetics of CRM1 to S5 and S8. Figure 1—source data 4. The data of affinities and binding kinetics of CRM1 to LFS-1107 and KPT-330.
    Deep Reinforcement Learning Based Molecular De Novo Design Method, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/deep reinforcement learning based molecular de novo design method/product/AstraZeneca ltd
    Average 90 stars, based on 1 article reviews
    deep reinforcement learning based molecular de novo design method - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    Image Search Results


    List of companies using AI and ML technologies in pharmaceutical research as discussed by [ <xref ref-type= 102 , 103 , 104 ]." width="100%" height="100%">

    Journal: Pharmaceutics

    Article Title: Artificial Intelligence and Internet of Things Integration in Pharmaceutical Manufacturing: A Smart Synergy

    doi: 10.3390/pharmaceutics17030290

    Figure Lengend Snippet: List of companies using AI and ML technologies in pharmaceutical research as discussed by [ 102 , 103 , 104 ].

    Article Snippet: 2 , Molecular Discovery , Deep learning platform for structure-based drug design , AtomWise.

    Techniques: Mutagenesis, Drug discovery, Software, Selection, Clinical Proteomics

    ( A ) The identification of ten commercial-accessible aromatic fragments aided by deep reinforcement learning model; ( B ) Synthesis of LFS-1107 via the installation of aromatic tetrazole moiety selected from the previous step to the sulforaphene parent structure; ( C ) Assessment of protein-ligand binding kinetics and binding affinity of tetrazole aromatic fragments via Bio-layer interferometry (BLI) assay; ( D ) Binding affinity of LFS-1107 and KPT-330 determined via BLI assay: LFS-1107, K d ~1.25E-11 M; KPT-330: K d ~5.29E-09 M. Figure 1—source data 1. The chemical structure of 10 commercial-accessible aromatic fragments. Figure 1—source data 2. The synthesis of compound LFS-1107. Figure 1—source data 3. The data of affinities and binding kinetics of CRM1 to S5 and S8. Figure 1—source data 4. The data of affinities and binding kinetics of CRM1 to LFS-1107 and KPT-330.

    Journal: eLife

    Article Title: Discovery and biological evaluation of a potent small molecule CRM1 inhibitor for its selective ablation of extranodal NK/T cell lymphoma

    doi: 10.7554/eLife.80625

    Figure Lengend Snippet: ( A ) The identification of ten commercial-accessible aromatic fragments aided by deep reinforcement learning model; ( B ) Synthesis of LFS-1107 via the installation of aromatic tetrazole moiety selected from the previous step to the sulforaphene parent structure; ( C ) Assessment of protein-ligand binding kinetics and binding affinity of tetrazole aromatic fragments via Bio-layer interferometry (BLI) assay; ( D ) Binding affinity of LFS-1107 and KPT-330 determined via BLI assay: LFS-1107, K d ~1.25E-11 M; KPT-330: K d ~5.29E-09 M. Figure 1—source data 1. The chemical structure of 10 commercial-accessible aromatic fragments. Figure 1—source data 2. The synthesis of compound LFS-1107. Figure 1—source data 3. The data of affinities and binding kinetics of CRM1 to S5 and S8. Figure 1—source data 4. The data of affinities and binding kinetics of CRM1 to LFS-1107 and KPT-330.

    Article Snippet: In the present study, we adopted the deep reinforcement learning based molecular de novo design method developed by Olivecrona etc. from AstraZeneca.

    Techniques: Ligand Binding Assay, Binding Assay